세계의 체외 대장암 스크리닝 검사 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2034년)
In-vitro Colorectal Cancer Screening Tests Market (Test Type: Fecal DNA Test Kits, Fecal immunochemical Test (FIT), Guaiac Fecal Occult Blood Test (gFOBT) Kits, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
상품코드:1530982
리서치사:Transparency Market Research
발행일:2024년 06월
페이지 정보:영문 120 Pages
라이선스 & 가격 (부가세 별도)
한글목차
체외 대장암 스크리닝 검사 시장 - 조사 범위
TMR의 조사 보고서 '체외 대장암 스크리닝 검사 세계 시장'은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회에 대해서도 조사했습니다. 본 보고서에서는 2024년을 기준년, 2034년을 예측년으로 하여 2018년부터 2034년까지 세계의 체외 대장암 스크리닝 검사 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 체외 대장암 스크리닝 검사 시장의 복합 연간 성장률(CAGR%)도 제공합니다.
이 보고서는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서 분석가는 KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체와의 인터뷰를 실시했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참조하여 체외 대장암 스크리닝 검사 시장을 추찰했습니다.
시장 현황
2023년 시장 규모
12억 달러
2034년 시장 규모
25억 달러
CAGR
7.1%
본 보고서에서는 세계의 체외 대장암 스크리닝 검사 시장 경쟁 구도에 대해 전해드립니다. 세계의 체외 대장암 스크리닝 검사 시장에서 사업을 전개하는 주요 기업이 특정되어 각 기업이 다양한 속성으로 프로파일 되고 있습니다. 기업 개요, 재무 상황, 최근 동향, SWOT 등이 본 보고서에서 소개되고 있는 세계의 체외 대장암 스크리닝 검사 시장에서의 기업의 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약: 세계 시장
제4장 시장 개요
소개
개요
시장 역학
세계 시장 분석과 예측, 2020-2034년
제5장 주요 인사이트
Porter's Five Forces 분석
주요 산업 이벤트
암의 유병률
제6장 세계 시장 분석과 예측 : 테스트 유형별
소개 및 정의
주요 조사 결과/진전
시장 매출 예측 : 테스트 유형별, 2020-2034년
대변 DNA 검사 키트
대변 면역화학 검사(FIT)
구아이악 대변 잠혈검사(gFOBT) 키트
기타
테스트 유형별 시장의 매력
제7장 세계 시장 분석과 예측 : 최종 사용자별
소개 및 정의
주요 조사 결과/진전
시장 매출 예측 : 최종사용자별, 2020-2034년
병원 및 클리닉
진단센터
기타
최종 사용자별 시장의 매력
제8장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 :지역별
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
국가, 지역별 시장의 매력
제9장 북미 시장 분석과 예측
미국
캐나다
제10장 유럽 시장 분석과 예측
독일
영국
프랑스
이탈리아
스페인
기타 유럽
제11장 아시아태평양 시장 분석과 예측
중국
인도
일본
호주 및 뉴질랜드
기타 아시아태평양
제12장 라틴아메리카 시장 분석과 예측
브라질
멕시코
기타 라틴아메리카
제13장 중동 및 아프리카 시장 분석과 예측
GCC 국가
남아프리카
기타 중동 및 아프리카
제14장 경쟁 구도
시장 기업-경쟁 매트릭스(기업 Tier과 규모별)
시장 점유율 분석기업별(2023년)
기업 프로파일
Abbott Laboratories
Thermofisher Scientific Inc.
Eiken Chemical Co., Ltd
Qiagen
Quest Diagnostics Incorporated
Sentinel CH. SpA
Quidel Corporation
Freenome Holdings, Inc.
Immunostics, Inc.
BTNX, Inc.
JHS
영문 목차
영문목차
In-vitro Colorectal Cancer Screening Tests Market - Scope of Report
TMR's report on the global in-vitro colorectal cancer screening tests market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global in-vitro colorectal cancer screening tests market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in-vitro colorectal cancer screening tests market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the in-vitro colorectal cancer screening tests market.
Market Snapshot
Market Value in 2023
US$ 1.2 Bn
Market Value in 2034
US$ 2.5 Bn
CAGR
7.1%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in-vitro colorectal cancer screening tests market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global in-vitro colorectal cancer screening tests market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in-vitro colorectal cancer screening tests market.
The report delves into the competitive landscape of the global in-vitro colorectal cancer screening tests market. Key players operating in the global in-vitro colorectal cancer screening tests market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in-vitro colorectal cancer screening tests market profiled in this report.
Key Questions Answered in Global in-vitro colorectal cancer screening tests Market Report:
What is the sales/revenue generated by in-vitro colorectal cancer screening tests across all regions during the forecast period?
What are the opportunities in the global in-vitro colorectal cancer screening tests market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
In-vitro Colorectal Cancer Screening Tests Market - Research Objectives and Research Approach
The comprehensive report on the global in-vitro colorectal cancer screening tests market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global in-vitro colorectal cancer screening tests market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in-vitro colorectal cancer screening tests market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global In-vitro Colorectal Cancer Screening Tests Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Porter's Five Force Analysis
5.2. Key Industry Events
5.3. Prevalence of Cancer
6. Global In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecasts, By Test Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Test Type, 2020-2034
6.3.1. Fecal DNA Test Kits
6.3.2. Fecal immunochemical Test (FIT)
6.3.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
6.3.4. Others
6.4. Market Attractiveness By Test Type
7. Global In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecasts, By End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By End-user, 2020-2034
7.3.1. Hospitals & Clinics
7.3.2. Diagnostic Centers
7.3.3. Others
7.4. Market Attractiveness By End-user
8. Global In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Market Value Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness By Country/Region
9. North America In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast By Test Type, 2020-2034
9.2.1. Fecal DNA Test Kits
9.2.2. Fecal immunochemical Test (FIT)
9.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
9.2.4. Others
9.3. Market Value Forecast By End-user, 2020-2034
9.3.1. Hospitals & Clinics
9.3.2. Diagnostic Centers
9.3.3. Others
9.4. Market Value Forecast By Country, 2020-2034
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Test Type
9.5.2. By End-user
9.5.3. By Country
10. Europe In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Test Type, 2020-2034
10.2.1. Fecal DNA Test Kits
10.2.2. Fecal immunochemical Test (FIT)
10.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
10.2.4. Others
10.3. Market Value Forecast By End-user, 2020-2034
10.3.1. Hospitals & Clinics
10.3.2. Diagnostic Centers
10.3.3. Others
10.4. Market Value Forecast By Country, 2020-2034
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Test Type
10.5.2. By End-user
10.5.3. By Country
11. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Test Type, 2020-2034
11.2.1. Fecal DNA Test Kits
11.2.2. Fecal immunochemical Test (FIT)
11.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
11.2.4. Others
11.3. Market Value Forecast By End-user, 2020-2034
11.3.1. Hospitals & Clinics
11.3.2. Diagnostic Centers
11.3.3. Others
11.4. Market Value Forecast By Country, 2020-2034
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Test Type
11.5.2. By End-user
11.5.3. By Country
12. Latin America In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Test Type, 2020-2034
12.2.1. Fecal DNA Test Kits
12.2.2. Fecal immunochemical Test (FIT)
12.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
12.2.4. Others
12.3. Market Value Forecast By End-user, 2020-2034
12.3.1. Hospitals & Clinics
12.3.2. Diagnostic Centers
12.3.3. Others
12.4. Market Value Forecast By Country, 2020-2034
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Test Type
12.5.2. By End-user
12.5.3. By Country
13. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Test Type, 2020-2034
13.2.1. Fecal DNA Test Kits
13.2.2. Fecal immunochemical Test (FIT)
13.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits
13.2.4. Others
13.3. Market Value Forecast By End-user, 2020-2034
13.3.1. Hospitals & Clinics
13.3.2. Diagnostic Centers
13.3.3. Others
13.4. Market Value Forecast By Country, 2020-2034
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Test Type
13.5.2. By End-user
13.5.3. By Country
14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis By Company (2023)
14.3. Company Profiles
14.3.1. Abbott Laboratories
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Thermofisher Scientific Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Eiken Chemical Co., Ltd
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Qiagen
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Quest Diagnostics Incorporated
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Sentinel CH. SpA
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Quidel Corporation
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Freenome Holdings, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.9. Immunostics, Inc.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.10. BTNX, Inc.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
